Neurodegenerative diseases: UniTrento takes on the challenge
A research team has been using RNA strands as weapon and target for over 10 years, and invented a treatment approach that was patented in Europe and in the USA. More time and investments are needed to develop it into a therapeutic treatment, but this genetic mechanism, which works like a key in the lock, is very promising
Cancer research, the guardian of the genome has a new ally
A study by the University of Trento identified a protein that, like a switch, controls the onset of cell death processes in cancer cells, which are regulated by p53, the protein known as ‘the guardian of the genome’. The findings, published in Cell Reports, will be used to develop more tailored and effective cancer treatments
On demand glass is right around the corner
A research group coordinated by physicists of the University of Trento was able to probe internal stress in colloidal glasses, a crucial step to control the mechanical properties of glasses. Their work opens the way to new types of glass for new applications. The study was published in the US journal "Science advances"
Covid-19, a prominent role for UniTrento in ultrasound diagnosis
A GPS of the brain that organizes concepts
A research group of CIMeC of the University of Trento found out that the same brain areas and coding schemes are activated when navigating through geographical and conceptual spaces. The study, which for the first time indicates that the same spatial maps are used for places and ideas, appeared in the “Journal of Neuroscience”
UniTrento in the very first Society Quest Event
ECIU University places the challenge-based approach at the centre of its pedagogics, research and innovation. The main idea is to bring the outside world into the curriculum. To do so, one of its members, Linköping University, hosted the very first European Society Quest Event yesterday. University of Trento with Trento Municipality and HIT Innovation Hub participated
Organoids to study pediatric brain tumors
Hundreds of Organoids (miniature brains) were grown in the laboratories of the University of Trento to study the genetic mechanisms responsible for the most common brain cancer affecting children. The results of a collaborative research effort, coordinated by the University of Trento and carried out with Sapienza University and Ospedale pediatrico Bambino Gesù in Rome and Irccs Neuromed, were published today in Nature Communications. The study will open new perspectives of research, as the large-scale production of in vitro tumors could make it possible to perform large drug screenings to identify new brain cancer drugs
Cibio knocks out cystic fibrosis
A research team of the University of Trento used genome editing to permanently correct two of the mutations that cause the disease. Instead of animal models, organoids derived from patients' cells were used in this study. The research work was carried out in collaboration with KU Leuven, in Belgium, with support from the Italian foundation for research on cystic fibrosis and the participation of the Cystic fibrosis association of Trentino. The results were published today in "Nature Communications"